BioLineRx Ltd (BLRX):企業の財務・戦略的SWOT分析

◆英語タイトル:BioLineRx Ltd (BLRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH10103FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioLineRx Ltd (BLRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the development of products related to cancer and immunology. Its pipeline product BL-8040 is a short peptide that is in Phase IIb clinical trial studies for acute myeloid leukemia (AML), Phase III studies for autologous transplantation and completed Phase IIa clinical trials for relapsed or refractory AML. The company’s other pipeline drug candidate AGI-134 is synthetic alpha-gal immunotherapy that finds application in the treatment of solid tumors. BioLineRx’s only product BL-5010 is a novel medical device indicated for non-surgical removal of skin lesions. BioLineRx is headquartered in Modi’in, Israel.

BioLineRx Ltd Key Recent Developments

Nov 23,2020: BioLineRx biolinerx reports third quarter 2020 financial results and provides corporate update
Aug 06,2020: BioLineRx reports second quarter 2020 financial results and provides corporate update
May 20,2020: BioLineRx reports first quarter 2020 financial results and provides corporate update
Mar 12,2020: BioLineRx reports year-end 2019 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioLineRx Ltd – Key Facts
BioLineRx Ltd – Key Employees
BioLineRx Ltd – Key Employee Biographies
BioLineRx Ltd – Major Products and Services
BioLineRx Ltd – History
BioLineRx Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioLineRx Ltd – Business Description
BioLineRx Ltd – Corporate Strategy
BioLineRx Ltd – SWOT Analysis
SWOT Analysis – Overview
BioLineRx Ltd – Strengths
BioLineRx Ltd – Weaknesses
BioLineRx Ltd – Opportunities
BioLineRx Ltd – Threats
BioLineRx Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioLineRx Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 23, 2020: BioLineRx biolinerx reports third quarter 2020 financial results and provides corporate update
Aug 06, 2020: BioLineRx reports second quarter 2020 financial results and provides corporate update
May 20, 2020: BioLineRx reports first quarter 2020 financial results and provides corporate update
Mar 12, 2020: BioLineRx reports year-end 2019 financial results and provides corporate update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioLineRx Ltd, Key Facts
BioLineRx Ltd, Key Employees
BioLineRx Ltd, Key Employee Biographies
BioLineRx Ltd, Major Products and Services
BioLineRx Ltd, History
BioLineRx Ltd, Subsidiaries
BioLineRx Ltd, Key Competitors
BioLineRx Ltd, Ratios based on current share price
BioLineRx Ltd, Annual Ratios
BioLineRx Ltd, Annual Ratios (Cont...1)
BioLineRx Ltd, Interim Ratios
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioLineRx Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioLineRx Ltd (BLRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenaga Nasional Berhad (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Berhad (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Savannah Resources Plc:企業のM&A・事業提携・投資動向
    Savannah Resources Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Savannah Resources Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Singapore Press Holdings Ltd (T39):企業の財務・戦略的SWOT分析
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • BRF SA:企業の戦略・SWOT・財務情報
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Medical Transcription Billing Corp (MTBC):医療機器:M&Aディール及び事業提携情報
    Summary Medical Transcription Billing Corp (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Mirach Energy Ltd (AWO):企業の財務・戦略的SWOT分析
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • Warner Music Group Corp:企業の戦略的SWOT分析
    Warner Music Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • Concept Packaging Group:企業の戦略・SWOT・財務情報
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Essential Energy Services Ltd (ESN):石油・ガス:M&Aディール及び事業提携情報
    Summary Essential Energy Services Ltd (Essential Energy) is an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipment rental …
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • KCB Group Plc.:企業の戦略・SWOT・財務情報
    KCB Group Plc. - Strategy, SWOT and Corporate Finance Report Summary KCB Group Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務情報
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PPL Corporation (PPL):電力:M&Aディール及び事業提携情報
    Summary PPL Corporation (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆